{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:43:46Z","timestamp":1791546226916,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["694913"],"award-info":[{"award-number":["694913"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["MA 2186\/14-1"],"award-info":[{"award-number":["MA 2186\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kroner-Fresenius Foundation","doi-asserted-by":"publisher","award":["2015_A171"],"award-info":[{"award-number":["2015_A171"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kroner-Fresenius Foundation","doi-asserted-by":"publisher","award":["2013_A182"],"award-info":[{"award-number":["2013_A182"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.atherosclerosis.2024.118591","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T06:53:14Z","timestamp":1725605594000},"page":"118591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Endothelial epoxyeicosatrienoic acid release is intact in aldosterone excess"],"prefix":"10.1016","volume":"398","author":[{"given":"Yao","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynur","family":"Bilyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mederos y Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Kocabiyik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gudermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Riols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Haid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jair G.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Horak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Koletzko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Adolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1556-0951","authenticated-orcid":false,"given":"Holger","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.118591_bib1","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","article-title":"Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan","volume":"71","author":"Ohno","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1152\/physrev.00004.2012","article-title":"Molecular biology of atherosclerosis","volume":"93","author":"Hopkins","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1507\/endocrj.K09E-014","article-title":"Endothelial dysfunction is related to aldosterone excess and raised blood pressure","volume":"56","author":"Tsuchiya","year":"2009","journal-title":"Endocr. J."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/HYPERTENSIONAHA.114.05001","article-title":"Effect of aldosterone-producing adenoma on endothelial function and rho-associated kinase activity in patients with primary aldosteronism","volume":"65","author":"Matsumoto","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib6","article-title":"Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism","volume":"1","author":"Kishimoto","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1530\/EC-21-0057","article-title":"Clinical impacts of endothelium-dependent flow-mediated vasodilation assessment on primary aldosteronism","volume":"10","author":"Watanabe","year":"2021","journal-title":"Endocrinol. Conn."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.HYP.0000171479.36880.17","article-title":"Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats","volume":"46","author":"Blanco-Rivero","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.HYP.21.3.294","article-title":"Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats","volume":"21","author":"Lariviere","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm1545","article-title":"Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity","volume":"13","author":"Leopold","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/01.HYP.0000226054.53527.bb","article-title":"Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity","volume":"48","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","article-title":"Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice","volume":"110","author":"Garnier","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib13","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1161\/01.CIR.101.25.2896","article-title":"Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes","volume":"101","author":"Taddei","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/FJC.0000000000000346","article-title":"Endothelium-dependent hyperpolarization and endothelial dysfunction","volume":"67","author":"F\u00e9l\u00e9tou","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.117.10644","article-title":"Downregulated serum 14, 15-epoxyeicosatrienoic acid is associated with abdominal aortic calcification in patients with primary aldosteronism","volume":"71","author":"Liu","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/CBB:47:1:87","article-title":"Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase","volume":"47","author":"Loch","year":"2007","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib17","first-page":"1","article-title":"Treatment of primary aldosteronism increases plasma epoxyeicosatrienoic acids","author":"Luther","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib19","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1073\/pnas.0804037106","article-title":"Aldosterone activates endothelial exocytosis","volume":"106","author":"Jeong","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/EJE-17-0978","article-title":"Primary aldosteronism : key characteristics at diagnosis : a trend toward milder forms","volume":"178","author":"Heinrich","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib21","first-page":"15","article-title":"Endothelial cell mineralocorticoid receptors oppose VEGF-induced gene expression and angiogenesis","volume":"240","author":"Moser","year":"2018","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1096\/fasebj.14.2.255","article-title":"Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca 2+ changes and dilation in isolated resistance arteries","volume":"14","author":"Bolz","year":"2000","journal-title":"Faseb. J."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/46816","article-title":"Cytochrome P450 2C is an EDHF synthase in coronary arteries","volume":"401","author":"Fisslthaler","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib24","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of derived eicosanoids","volume":"285","author":"Node","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib25","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1074\/jbc.RA117.000298","article-title":"Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia","volume":"293","author":"Edin","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1476-5381.1992.tb14307.x","article-title":"Endothelium\u2010dependent relaxation to acetylcholine in the rabbit basilar artery: importance of membrane hyperpolarization","volume":"106","author":"Rand","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1096\/fasebj.14.5.797","article-title":"Heterogeneity of [Ca 2+]i signaling in intact rat aortic endothelium","volume":"14","author":"Huang","year":"2000","journal-title":"Faseb. J."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib28","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1002\/jcp.27234","article-title":"Muscarinic M5 receptors trigger acetylcholine-induced Ca 2+ signals and nitric oxide release in human brain microvascular endothelial cells","volume":"234","author":"Zuccolo","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.HYP.0000153462.06604.5d","article-title":"14,15-Epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries","volume":"45","author":"Gauthier","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1152\/ajpheart.00927.2005","article-title":"Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKCa channels: implications for soluble epoxide hydrolase inhibition","volume":"290","author":"Larsen","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj5101","article-title":"Atlas of cardiac endothelial cell enhancer elements linking the mineralocorticoid receptor to pathological gene expression","volume":"10","author":"Deng","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib32","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1016\/S0021-9258(19)38526-6","article-title":"Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase","volume":"265","author":"Capdevila","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib33","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.bcp.2003.12.023","article-title":"Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid","volume":"67","author":"Schwarz","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib34","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/S0022-2275(20)35111-7","article-title":"14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells","volume":"34","author":"VanRollins","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib35","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1242\/dev.124.24.5075","article-title":"Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an \u201cadult\u201d acetylcholine receptor subunit","volume":"124","author":"Missias","year":"1997","journal-title":"Development (Cambridge, U. K.)"},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib36","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1124\/jpet.112.192229","article-title":"Activation of nicotinic receptors can contribute to endothelium-dependent relaxations to acetylcholine in the rat aorta","volume":"341","author":"Zou","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.atherosclerosis.2024.118591_bib37","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol."}],"updated-by":[{"DOI":"10.1016\/j.atherosclerosis.2024.119071","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000}}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024011638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:36:06Z","timestamp":1777444566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024011638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":37,"alternative-id":["S0021915024011638"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118591","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial epoxyeicosatrienoic acid release is intact in aldosterone excess","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"118591"}}